Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Thomas

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Blood|June 21, 2008
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeStefan Faderl, Farhad Ravandi, Xuelin Huang, et al.
Cancer|August 12, 2003
Phase II study of alemtuzumab in chronic lymphoproliferative disordersAlessandra Ferrajoli, Susan M O'Brien, Jorge E Cortes, et al.
Blood|August 2, 2003
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemiaIman Jilani, Susan O'Brien, Taghi Manshuri, et al.
Blood|May 31, 2002
Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosideElihu H Estey, Peter F Thall, Francis J Giles, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2010
A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaZhuang Zuo, Dan Jones, Hui Yao, et al.
Cancer|July 14, 2011
Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trialMaria E Cabanillas, Hagop Kantarjian, Deborah A Thomas, et al.
Annals of Hematology|October 25, 2013
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growthHongbo Lu, Kensuke Kojima, Venkata Lokesh Battula, et al.
Blood|August 30, 2003
Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 settingRazelle Kurzrock, Hagop M Kantarjian, Jorge E Cortes, et al.
Cancer|August 14, 2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphomaBouthaina S Dabaja, Chul S Ha, Deborah A Thomas, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Blood|June 21, 2008
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeStefan Faderl, Farhad Ravandi, Xuelin Huang, et al.
Cancer|August 12, 2003
Phase II study of alemtuzumab in chronic lymphoproliferative disordersAlessandra Ferrajoli, Susan M O'Brien, Jorge E Cortes, et al.
Blood|August 2, 2003
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemiaIman Jilani, Susan O'Brien, Taghi Manshuri, et al.
Blood|May 31, 2002
Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosideElihu H Estey, Peter F Thall, Francis J Giles, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2010
A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaZhuang Zuo, Dan Jones, Hui Yao, et al.
Cancer|July 14, 2011
Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trialMaria E Cabanillas, Hagop Kantarjian, Deborah A Thomas, et al.
Annals of Hematology|October 25, 2013
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growthHongbo Lu, Kensuke Kojima, Venkata Lokesh Battula, et al.
Blood|August 30, 2003
Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 settingRazelle Kurzrock, Hagop M Kantarjian, Jorge E Cortes, et al.
Cancer|August 14, 2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphomaBouthaina S Dabaja, Chul S Ha, Deborah A Thomas, et al.
Pageof 11